Literature DB >> 27196547

Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.

Andrea Antinori1, Simone Marcotullio2, Massimo Andreoni3, Antonio Chirianni4, Antonella d'Arminio Monforte5, Antonio Di Biagio6, Massimo Galli7, Francesco Mazzotta8, Cristina Mussini9, Massimo Puoti10, Adriano Lazzarin11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27196547

Source DB:  PubMed          Journal:  New Microbiol        ISSN： 1121-7138            Impact factor:   2.479


× No keyword cloud information.
  7 in total

Review 1.  Treating HIV Infection in the Central Nervous System.

Authors:  A Calcagno; G Di Perri; S Bonora
Journal:  Drugs       Date:  2017-02       Impact factor: 9.546

2.  Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.

Authors:  Nicola Gianotti; Alessandro Cozzi-Lepri; Andrea Antinori; Antonella Castagna; Andrea De Luca; Benedetto Maurizio Celesia; Massimo Galli; Cristina Mussini; Carmela Pinnetti; Vincenzo Spagnuolo; Antonella d'Arminio Monforte; Francesca Ceccherini-Silberstein; Massimo Andreoni
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

3.  Comparison of the Aptima HIV-1 Quant Dx assay with the COBAS AmpliPrep/COBAS TaqMan HIV-1 v2.0 Test for HIV-1 viral load quantification in plasma samples from HIV-1-infected patients.

Authors:  Serena Longo; Isabella Bon; Giuseppina Musumeci; Alessia Bertoldi; Vanessa D'Urbano; Leonardo Calza; Maria Carla Re
Journal:  Health Sci Rep       Date:  2018-03-13

4.  Continuum of care among HIV-1 positive patients in a single center in Italy (2007-2017).

Authors:  Filippo Lagi; Seble Tekle Kiros; Irene Campolmi; Susanna Giachè; Pier Giorgio Rogasi; Marcello Mazzetti; Filippo Bartalesi; Michele Trotta; Patrizia Nizzoli; Alessandro Bartoloni; Gaetana Sterrantino
Journal:  Patient Prefer Adherence       Date:  2018-11-30       Impact factor: 2.711

5.  Role of pretreatment variables on plasma HIV RNA value at the sixth month of antiretroviral therapy including all first line drugs in HIV naïve patients: A path analysis approach.

Authors:  Carlo Mengoli; Monica Basso; Samantha Andreis; Renzo Scaggiante; Mario Cruciani; Roberto Ferretto; Sandro Panese; Vinicio Manfrin; Daniela Francisci; Elisabetta Schiaroli; Gaetano Maffongelli; Loredana Sarmati; Massimo Andreoni; Franco Baldelli; Giorgio Palu'; Saverio Giuseppe Parisi
Journal:  PLoS One       Date:  2019-03-11       Impact factor: 3.240

6.  Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study.

Authors:  Frank A Post; Pablo Tebas; Amanda Clarke; Laurent Cotte; William R Short; Michael E Abram; Shuping Jiang; Andrew Cheng; Moupali Das; Marshall W Fordyce
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

7.  Evolving treatment implementation among HIV-infected pregnant women and their partners: results from a national surveillance study in Italy, 2001-2015.

Authors:  Marco Floridia; Valentina Frisina; Marina Ravizza; Anna Maria Marconi; Carmela Pinnetti; Irene Cetin; Matilde Sansone; Atim Molinari; Francesca Cervi; Alessandra Meloni; Kety Luzi; Giulia Masuelli; Enrica Tamburrini
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.